Mission statement · Company scope
“Our mission is to transform cancer treatment by delivering innovative radioconjugates that maximize therapeutic efficacy while minimizing toxicity to healthy tissue by combining our deep understanding of tumor biology and translational medicine with our expertise in radiochemistry.”
In use2026 – now1 sighting
First seenMar 2026Added
Last seenMar 2026Latest observation
Date created—Not published by the organization
Record
- Kind
- Mission
- Scope
- Company
- Style
- Innovation (primary) · Impact
- Leads with
- Invention
- Best for
- Climate & health
- Formula
- We’re building [new thing] so [result]
- Tone
- Plain
- Length
- 37 words · reading grade 26.3
- Review status
- unreviewed · classifier rules-v0
- Quality score
- 0.60
- Record
- st_7c46d171d75f3a44
- Classification confidence
- 0.79
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2026-03-30 · sec_sentence · 10-K · accession 0001213900-26-036504
View filing ↗0 to compareCompare